The markets closed mixed with the Dow easing 3 points to 26,210 as investors weigh the impact of steep solar panel import tariffs. Nasdaq climbed 52 points to 7460.
On the upside
Shares of vTv Therapeutics (Nasdaq: VTVT) surged on no news.
Inovio Pharmaceuticals (Nasdaq: INO) announced that its synthetic flu vaccine protected multiple animal models from all major deadly strains of H1 influenza viruses from the last 100 year.
Chinese scientists have used CRISPR Therapeutics (Nasdaq: CRSP) technology to genetically engineer cells in 86 cancer and HIV patients.
On the downside
Obalon Therapeutics (Nasdaq: OBLN) terminated its public offering of more than 5.4 million common shares due to allegations of improper revenue recognition.
The Ledger Gazette wrote that Wendy's (Nasdaq: WEN) was a better business than Jamba (Nasdaq: JMBA).
Shares of JinkoSolar Holdings (NYSE: JKS) tumbled after President Donald Trump imposed steep tariffs on solar panel imports.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by nearly 4 to 3 on Nasdaq. The broader S&P 500 rose 6 points to 2,839. Bitcoin soared $316 to $10,995.
